Health
Italian COVID-19 vaccine shows strong immune response in mid-stage trial – bdnews24.com
Italy’s hopes of producing its own COVID-19 vaccine were given a boost on Monday when local biotech firm ReiThera said its vaccine…
The vaccine, called GRAd-COV2, induced an antibody response against the SARS-CoV-2 spike protein in over 93 percent of volunteers three weeks after the first dose, reaching 99 percent after the second dose, the company said in a statement.
However, ReiThera…
Continue Reading
-
General17 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News23 hours agoYork family honours late son with tractor museum to fund cancer research
-
General22 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Noosa News18 hours agoPerth Royal Show attendance slumps to 10-year low